Canbex.co.uk - Welcome to Canbex Therapeutics
Provided by Alexa ranking, canbex.co.uk
has ranked N/A
on the world. canbex.co.uk
reaches roughly 456
users per day and delivers about 13,684
users each month. The domain canbex.co.uk uses a Commercial suffix and it's server(s) are located in N/A
with the IP number 22.214.171.124
and it is a .co.uk
Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders. The goal of the Canbex lead programme is to set a new standard in the treatment of spasticity, through improved tolerability.
List of domain same IP 126.96.36.199
Search Results related to canbex.co.uk on Search Engine
Welcome to Canbex Therapeutics
Canbex Therapeutics is dedicated to discovering new medicines for rare neurological diseases. Inspired by the call of patients and their families, our mission is to build on cutting-edge research by scientific pioneers to find effective new treatments for devastating disorders of the brain and nervous system.
DA: 35 PA: 72 MOZ Rank: 38
Canbex Therapeutics - a client of LBIC London BioScience ...
Canbex Therapeutics is dedicated to improving the quality of life for people with multiple sclerosis through the treatment of spasticity, one of the disorder's most debilitating symptoms. The goal of the Canbex programme is to set a new standard in the treatment of spasticity, through improved tolerability.
DA: 80 PA: 46 MOZ Rank: 48
Canbex Therapeutics - Crunchbase Company Profile & Funding
Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders. Spasticity is a debilitating and painful symptom that consists of involuntary spasms and stiffness of limbs and torso. The goal of the Canbex lead programme is to improve the lives of people with this serious and incurable disorder, and set a ...
DA: 17 PA: 65 MOZ Rank: 30
Canbex Group - A leading provider of CBG and CBD products.
Canbex Group is the industrial division of the Bast Crops Institution, located in Hlukhiv, Ukraine. We are growing CBD and CBG with low THC levels at a very large scale. Our main advantages: The first Ukrainian group with an unlimited cultivation, transportation, storage, processing, sales, import and export license.
DA: 73 PA: 48 MOZ Rank: 40
Canbex Therapeutics Ltd - Company Profile and News ...
Canbex Therapeutics Ltd. Canbex Therapeutics Ltd. Researches and develops compounds for treatment of neurodegenerative diseases. The Company conducts business in the United Kingdom.
DA: 88 PA: 67 MOZ Rank: 44
Canbex Therapeutics Ltd – UCLB
Canbex Therapeutics Ltd Canbex is a spinout of University College London (UCL) that was established to develop its proprietary VSN compound series. In addition to its pioneering scientific founders and clinical advisors, Canbex has assembled a skilled and focused management team. Development activities are carried out through leading CROs and CMOs. The company’s capital efficiency
DA: 36 PA: 83 MOZ Rank: 10
CANBEX THERAPEUTICS LIMITED - Overview (free company ...
CANBEX THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity
DA: 46 PA: 98 MOZ Rank: 27
Canbex Therapeutics Receives £1.75 million (USD 2.8 ...
Canbex is a virtual, low-burn company that was set up as a vehicle for the development of the VSN compounds. Building on the expertise of its founders Canbex has assembled a highly experienced team with expertise in pharmacology, medicinal chemistry, preclinical and clinical development, finance and business development.
DA: 87 PA: 32 MOZ Rank: 51
Canbex Archives - Lucy J Robertshaw
Keith Powell Chairman of Domainex, Biomoti and Canbex said London is number 10 for cities investing in life sciences and asks, why is that? He also says Mayor Boris’ idea of a mega fund disappeared and the solution the next Mayor of London can explore is to fund at least £10 million a year to take academia to market. Breakfast and networking
DA: 37 PA: 40 MOZ Rank: 18
Canbex Therapeutics Ltd receives new investment from Fast ...
Canbex is a virtual, low-burn company that was set up as a vehicle for the development of VSN compounds. Building on the expertise of its founders, Canbex has assembled a highly experienced team of experts in pharmacology, medicinal chemistry, preclinical and clinical development, finance and business development.
DA: 100 PA: 54 MOZ Rank: 97
Alexa Rank Country N/A
Daily Unique Visitors
Monthly Unique Visitors
Vistor via Country
Alexa Traffic Graph
Alexa daily traffic trend graph
Alexa daily pageviews (percent) graph
Alexa daily pageviews per user graph
Alexa time on site (in minutes) graph
Alexa bounce rate (percent) graph
Alexa search visits graph
||Welcome to Canbex Therapeutics
||Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders. The goal of the Canbex lead programme is to set a new standard in the treatment of spasticity, through improved tolerability.
|| Canbex Therapeutics, treating spasticity, Multiple Sclerosis Society, VSN16R, Phase I human safety trials.
Mini site formation by Alexa Rank
||Txt: v=spf1 include:spf.protection.outlook.com -all
Entries_0: v=spf1 include:spf.protection.outlook.com -all
Hosting and Whois Zone
||Error: No appropriate Whois server found for canbex.co.uk domain!
Nominet was able to match the registrant's name and address against a 3rd party data source on 10-Dec-2012
Dominic Handy t/a Domain Devils [Tag = EVERYONE]
Registered on: 14-Sep-2007
Expiry date: 14-Sep-2021
Last updated: 02-Sep-2019
Registered until expiry date.
WHOIS lookup made at 19:10:35 25-Oct-2020
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2020.
You may not access the .uk WHOIS or use any data from it except as permitted
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.